# Role of Myeloid-derived Suppressor Cells In Primary Myelofibrosis

> **NCT07319026** · — · COMPLETED · sponsor: **Fondazione IRCCS Policlinico San Matteo di Pavia** · enrollment: 70 (actual)

## Conditions studied

- Primary Myelofibrosis (PMF)
- Healthy Subjects

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07319026
- **Lead sponsor:** Fondazione IRCCS Policlinico San Matteo di Pavia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-14
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07319026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07319026, "Role of Myeloid-derived Suppressor Cells In Primary Myelofibrosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07319026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*